Product Information
BUDESONIDE 1 MG/2 ML INH SUSP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $3.4274 per ML under NDC 00093681773. Its NADAC has been published 549 times since Mar 30, 2016.
FDA first approved this application on Mar 8, 2016. Its Orange Book therapeutic-equivalence code is AN.
Strength
1 mg/2mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093681773
Classification
Generic
Dosage Form
SUSPENSION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204548FDA Approved
3/8/2016
TE Code
AN
On Market Since
3/11/2016
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE 1 MG/2 ML INH SUSP has been published 549 times since Mar 30, 2016, and over the history we have for it it has declined 61.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4274 per ML |
|---|---|
| All-time high | $9.2761 (Nov 16, 2016) |
| All-time low | $2.9762 (May 22, 2024) |
| 52-week high | $4.3341 |
| 52-week low | $3.4274 |
| Median price | $4.1951 |
| Average price | $4.8525 |
| Largest weekly change | -26.6% (Apr 17, 2024) |
| Weeks tracked | 549 |
| Tracking since | Mar 30, 2016 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Budesonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUDESONIDE 1 MG/2 ML INH SUSP?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE 1 MG/2 ML INH SUSP, manufactured by Teva Pharmaceuticals USA Inc., is $3.4274 per ML (NDC 00093681773), effective Sep 30, 2026.
How has the price of BUDESONIDE 1 MG/2 ML INH SUSP changed over time?
Over the history we have for it, the NADAC for BUDESONIDE 1 MG/2 ML INH SUSP has declined 61.4%. It has been tracked across 549 weekly CMS publications since Mar 30, 2016.
What are the highest and lowest recorded NADAC prices for BUDESONIDE 1 MG/2 ML INH SUSP?
Since Mar 30, 2016, the NADAC for BUDESONIDE 1 MG/2 ML INH SUSP has ranged from a low of $2.9762 (May 22, 2024) to a high of $9.2761 (Nov 16, 2016), with a median of $4.1951 per ML.
Are there cheaper alternatives to BUDESONIDE 1 MG/2 ML INH SUSP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUDESONIDE 1 MG/2 ML INH SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures BUDESONIDE 1 MG/2 ML INH SUSP?
BUDESONIDE 1 MG/2 ML INH SUSP (NDC 00093681773) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.